Department of Human Genetics, Leiden University
Leiden, NL
https://www.universiteitleiden.nl/en/staffmembers/annemieke-aartsma-rus
Guest speaker
Session IV: Technology and applications development (e.g. Aptamers, RNAi, snRNAs, ASO)
Helmholtz Research Center Juelich, Heinrich-Heine-University Duesseldorf
Duesseldorf, DE
http://www.etzkornlab.de/
Guest speaker
Session IV: Technology and applications development (e.g. Aptamers, RNAi, snRNAs, ASO)
St. Jude Children's Research Hospital
Memphis, US
https://www.stjude.org/directory/f/richard-finkel.html
Guest speaker
Session VI: Preclinical and Clinical Application
Dept. of Molecular Biology & Biochemistry, Rutgers University
Piscataway, US
https://molbiosci.rutgers.edu/faculty-research/faculty/faculty-detail/82-g-h/151-sam-gunderson
Guest speaker
Session IV: Technology and applications development (e.g. Aptamers, RNAi, snRNAs, ASO)
Dept. of Surgery & Cancer, Hammersmith Hospital, Imperial College London
London, GB
https://www.imperial.ac.uk/people/nagy.habib
Guest speaker
Session IV: Technology and applications development (e.g. Aptamers, RNAi, snRNAs, ASO)
Dept. of Chemistry, Dept. of Biochemistry, Duke University
Durham, US
https://hargrovelab.chem.duke.edu/about/people/
Guest speaker
Session V: CRISP and RNA-protein interaction and modulation
European Molecular Biology Laboratory (EMBL)
Heidelberg, DE
https://www.embl.org/groups/hentze/
Guest speaker
Session V: CRISP and RNA-protein interaction and modulation
ETH Zurich
Zurich, CH
https://protein.ethz.ch/the-group/group-members/hilvert-donald.html
Guest speaker
Session II: Nucleic Acids Delivery and Visualization
Inst. of Organic Chemistry, University of Wuerzburg
Wuerzburg, DE
https://www.chemie.uni-wuerzburg.de/oc/hoebartner-group/home/
Guest speaker
Session III: Technology and future applications (e.g. mRNAs, ncRNAs)
Gene Center and Department of Biochemistry, Ludwig-Maximilians-University Munich
Munich, DE
https://www.genzentrum.uni-muenchen.de/research-groups/hornung/index.html
Guest speaker
Session I: Nucleic Acid Chemistry (Innate Immunity)
Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg
Heidelberg, DE
https://www.jaschkelab.de/contact
Guest speaker
Session II: Nucleic Acids Delivery and Visualization
Dept. of Molecular Biology and Genetics, Cornell University
Ithaca, US
https://cals.cornell.edu/ailong-ke
Guest speaker
Session V: CRISP and RNA-protein interaction and modulation
Alnylam Pharmaceuticals, Inc, Senior VP of Drug Innovation Chemistry
Cambridge, US
https://www.alnylam.com/our-science/alnylam-scientific-advisory-board
Guest speaker
Session I: Nucleic Acid Chemistry (Innate Immunity)
Dept. of Internal Medicine and Division of Nephrology, UT Southwestern Medical Center Dallas
Dallas, US
https://profiles.utsouthwestern.edu/profile/67937/vishal-patel.html
Guest speaker
Session III: Technology and future applications (e.g. mRNAs, ncRNAs)
Institute of Biochemistry, University of Muenster
Muenster, DE
https://www.uni-muenster.de/Chemie.bc/en/forschung/rentmeister/index.html
Guest speaker
Session I: Nucleic Acid Chemistry (Innate Immunity)
Inst. of Pharmacology and Toxicology, University of Zurich
Zurich, CH
https://schwanklab.org/
Guest speaker
Session V: CRISP and RNA-protein interaction and modulation
College of Law, University of Illinois
Urbana-Champaign, US
https://law.illinois.edu/faculty-research/faculty-profiles/jacob-s-sherkow/
Guest speaker
Session VI: Preclinical and Clinical Application
Royal School of Mines, Imperial College London
London, GB
https://www.stevensgroup.org/professor-stevens
Guest speaker
Session III: Technology and future applications (e.g. mRNAs, ncRNAs)
Inst. for Molecular Health Sciences, ETH Zurich
Zurich, CH
https://mhs.biol.ethz.ch/research/stoffel.html
Keynote speaker
CMMC Lecture I
Department of Surgery, Duke University
Durham, US
https://surgery.duke.edu/profile/bruce-alan-sullenger
Guest speaker
Session IV: Technology and applications development (e.g. Aptamers, RNAi, snRNAs, ASO)
Dept. of Molecular Genetics and Microbiology, University of Florida
Gainesville, US
https://mgm.ufl.edu/faculty/swanson-maurice-s/
Guest speaker
Session III: Technology and future applications (e.g. mRNAs, ncRNAs)
Huntington’s Disease Centre and Dept. of Neurodegenerative Disease, National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology
London, GB
https://www.ucl.ac.uk/school-life-medical-sciences/sarah-tabrizi
Guest speaker
Session VI: Preclinical and Clinical Application
Laboratory of RNA Molecular Biology, The Rockefeller University
New York City, US
https://www.rockefeller.edu/our-scientists/heads-of-laboratories/911-thomas-tuschl/
Guest speaker
Session V: CRISP and RNA-protein interaction and modulation
Alnylam Pharmaceuticals, Inc, President
Cambridge, US
https://www.alnylam.com/about-alnylam/alnylam-leadership
Keynote speaker
CMMC Lecture II
Cancer Vaccines, BioNTech SE
Mainz, DE
https://www.biontech.com/int/en/home.html
Guest speaker
Session II: Nucleic Acids Delivery and Visualization
Division of Gastroenterology and Hepatology, University of Hong Kong
Hong Kong, HK
https://medic.hku.hk/en/Staff/University-Academic-Staff/Prof-YUEN-Man-Fung/Prof-YUEN-Man-Fung-profile
Guest speaker
Session VI: Preclinical and Clinical Application